MedTrace Logo

Safety and Efficacy of an Injectable Medical Device to Treat Knee Osteoarthritis

NCT01365260 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-12-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether MM-II is effective in the treatment of osteoarthritis, in direct comparison with an approved hyaluronic acid preparation.

Conditions

Interventions

DEVICE

MM-II

Single intraarticular (knee) injection of MM-II

DEVICE

DurolaneTM

Single intraarticular (knee) injection of DurolaneTM

Sponsors & Collaborators

  • Moebius Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Leonid (Arieh) Kandel, MD · Hadassah Mount Scopus Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01365260 on ClinicalTrials.gov